Chemed CEO McNamara sells 4,000 common shares
PremiumThe FlyChemed CEO McNamara sells 4,000 common shares
2M ago
Chemed backs FY24 adjusted EPS view $23.30-$23.70, consensus $23.52
PremiumThe Fly
Chemed backs FY24 adjusted EPS view $23.30-$23.70, consensus $23.52
3M ago
Chemed reports Q1 adjusted EPS $5.20, consensus $5.48
PremiumThe Fly
Chemed reports Q1 adjusted EPS $5.20, consensus $5.48
3M ago
Chemed reports Q4 adjusted EPS $6.60, consensus $6.25
PremiumThe FlyChemed reports Q4 adjusted EPS $6.60, consensus $6.25
5M ago
Is CHE a Buy, Before Earnings?
PremiumPre-Earnings
Is CHE a Buy, Before Earnings?
5M ago
Chemed appoints Michael Witzeman as CFO, effective January 1
PremiumThe Fly
Chemed appoints Michael Witzeman as CFO, effective January 1
7M ago
Chemed reports Q3 adjusted EPS $5.32, consensus $4.90
PremiumThe FlyChemed reports Q3 adjusted EPS $5.32, consensus $4.90
9M ago
Chemed (CHE) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Chemed (CHE) Q3 Earnings Cheat Sheet
9M ago
Chemed management to meet with Oppenheimer
PremiumThe Fly
Chemed management to meet with Oppenheimer
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100